Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed software/version label has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site update rather than a change to the trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:26.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T21:27:04.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T18:55:04.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the updates relate to study status and contacts/locations within the record.
    Difference
    0.1%
    Check dated 2026-03-04T15:30:50.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page history. No study data or essential content was altered.
    Difference
    0.1%
    Check dated 2026-02-11T10:59:19.000Z thumbnail image

Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.